Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab Switch Study in RA
NCT00714493Phase 4Completed
- Sponsor
- Janssen Biotech
- Start
- Jul 2008
- Primary completion
- Jan 2010
- Modality
- Monoclonal Antibodies
- Countries
- 10
01
Overview
A Phase 4 trial of infliximab in rheumatoid arthritis (RA), sponsored by Janssen Biotech. Started Jul 2008; status: completed.
02
Drugs
infliximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00714493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00714493.